A detailed history of Fjarde Ap Fonden transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Fjarde Ap Fonden holds 73,069 shares of BMRN stock, worth $4.87 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
73,069
Previous 63,069 15.86%
Holding current value
$4.87 Million
Previous $5.51 Million 6.77%
% of portfolio
0.05%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$69.02 - $93.84 $690,200 - $938,400
10,000 Added 15.86%
73,069 $5.14 Million
Q1 2024

Apr 25, 2024

BUY
$83.81 - $99.0 $192,763 - $227,700
2,300 Added 3.78%
63,069 $5.51 Million
Q4 2023

Feb 14, 2024

SELL
$76.22 - $98.51 $868,908 - $1.12 Million
-11,400 Reduced 15.8%
60,769 $5.86 Million
Q3 2023

Oct 23, 2023

BUY
$85.07 - $94.48 $459,377 - $510,192
5,400 Added 8.09%
72,169 $6.39 Million
Q2 2023

Aug 02, 2023

BUY
$86.68 - $100.3 $69,344 - $80,240
800 Added 1.21%
66,769 $5.79 Million
Q1 2023

May 15, 2023

BUY
$87.74 - $117.27 $157,932 - $211,086
1,800 Added 2.81%
65,969 $6.41 Million
Q4 2022

Feb 14, 2023

SELL
$80.93 - $108.63 $1.11 Million - $1.49 Million
-13,700 Reduced 17.59%
64,169 $6.64 Million
Q2 2022

Aug 11, 2022

BUY
$71.48 - $86.85 $893,500 - $1.09 Million
12,500 Added 19.12%
77,869 $6.45 Million
Q1 2022

May 13, 2022

SELL
$74.28 - $92.69 $59,424 - $74,152
-800 Reduced 1.21%
65,369 $5.04 Million
Q4 2021

Feb 15, 2022

SELL
$71.72 - $91.47 $200,816 - $256,116
-2,800 Reduced 4.06%
66,169 $5.85 Million
Q3 2021

Nov 15, 2021

SELL
$74.77 - $85.47 $164,494 - $188,034
-2,200 Reduced 3.09%
68,969 $5.33 Million
Q2 2021

Aug 12, 2021

SELL
$75.51 - $84.79 $437,958 - $491,782
-5,800 Reduced 7.54%
71,169 $5.94 Million
Q1 2021

May 17, 2021

BUY
$74.73 - $90.69 $149,460 - $181,380
2,000 Added 2.67%
76,969 $5.81 Million
Q4 2020

Feb 12, 2021

SELL
$72.61 - $90.2 $101,654 - $126,280
-1,400 Reduced 1.83%
74,969 $6.57 Million
Q3 2020

Nov 13, 2020

BUY
$71.87 - $131.03 $395,285 - $720,665
5,500 Added 7.76%
76,369 $5.81 Million
Q2 2020

Aug 13, 2020

BUY
$79.55 - $124.22 $350,020 - $546,568
4,400 Added 6.62%
70,869 $8.74 Million
Q1 2020

May 11, 2020

BUY
$71.37 - $96.85 $435,357 - $590,785
6,100 Added 10.1%
66,469 $5.62 Million
Q4 2019

Feb 10, 2020

BUY
$64.27 - $86.37 $533,441 - $716,871
8,300 Added 15.94%
60,369 $5.1 Million
Q3 2019

Oct 31, 2019

BUY
$67.4 - $85.11 $647,040 - $817,056
9,600 Added 22.6%
52,069 $3.51 Million
Q2 2019

Jul 17, 2019

SELL
$80.35 - $93.9 $1.08 Million - $1.26 Million
-13,400 Reduced 23.98%
42,469 $3.64 Million
Q1 2019

Apr 29, 2019

BUY
$84.2 - $98.62 $825,833 - $967,264
9,808 Added 21.29%
55,869 $4.96 Million
Q4 2018

Jan 31, 2019

SELL
$80.14 - $106.07 $817,428 - $1.08 Million
-10,200 Reduced 18.13%
46,061 $3.92 Million
Q3 2018

Nov 09, 2018

SELL
$93.92 - $105.72 $91,947 - $103,499
-979 Reduced 1.71%
56,261 $5.46 Million
Q2 2018

Jul 12, 2018

BUY
$76.01 - $99.03 $193,825 - $252,526
2,550 Added 4.66%
57,240 $5.39 Million
Q1 2018

May 07, 2018

SELL
$77.67 - $92.63 $147,573 - $175,997
-1,900 Reduced 3.36%
54,690 $4.43 Million
Q4 2017

Feb 12, 2018

BUY
$80.76 - $95.13 $623,467 - $734,403
7,720 Added 15.8%
56,590 $5.05 Million
Q3 2017

Nov 07, 2017

SELL
$80.6 - $94.95 $68,832 - $81,087
-854 Reduced 1.72%
48,870 $4.55 Million
Q2 2017

Aug 08, 2017

BUY
N/A
49,724
49,724 $4.52 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Fjarde Ap Fonden Portfolio

Follow Fjarde Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.